Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Elsevier Congratulates Beth Karlan, MD, Editor-in-Chief of Gynecologic Oncology on Her Appointment to the National Cancer



    Elsevier Congratulates Beth Karlan, MD, Editor-in-Chief of Gynecologic
      Oncology on Her Appointment to the National Cancer Advisory Board

  PR Newswire

  LONDON, December 17, 2012

LONDON, December 17, 2012 /PRNewswire/ --

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, is pleased to congratulate Beth Karlan, MD,
Editor-in-Chief of Gynecologic Oncology on being appointed by U.S. President
Barack Obama to the National Cancer Advisory Board (NCAB), along with five
other leaders in cancer research.

The National Cancer Advisory Board, formed in 1971, has several
responsibilities including advising and assisting the proceedings of the
National Cancer Institute (NCI), one of 27 Institutes that make up the
National Institutes of Health (NIH). According to the NACB's charter, the
board's duties are to "review applications for grants for research and
training and recommend approval for applications for projects which show
promise of making valuable contributions to human knowledge." Allocating
resources and pursuing the best avenues for research is a crucial task, as the
NCI spends about $4.9 billion each year on cancer research.

Elsevier applauds Dr. Karlan's important work and her dedication to serving
the research community.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contacts Elizabeth Perill Elsevier +1-212-633-3833 e.perill@elsevier.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement